Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
Pre-Tax Income
Takeda Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Pre-Tax Income
¥148.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Pre-Tax Income
¥199.2B
|
CAGR 3-Years
35%
|
CAGR 5-Years
20%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Pre-Tax Income
¥142.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-5%
|
|
Eisai Co Ltd
TSE:4523
|
Pre-Tax Income
¥71.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Pre-Tax Income
¥443.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
30%
|
CAGR 10-Years
19%
|
|
Astellas Pharma Inc
TSE:4503
|
Pre-Tax Income
¥72.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-5%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
148.2B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Pre-Tax Income amounts to 148.2B JPY.
What is Takeda Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-1%
Over the last year, the Pre-Tax Income growth was -46%. The average annual Pre-Tax Income growth rates for Takeda Pharmaceutical Co Ltd have been 8% over the past three years , 1% over the past five years , and -1% over the past ten years .